Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract
"Express Scripts is proud to continue providing world-class service and specialized pharmacy care to our men and women in uniform, along with their dependents and also to military retirees," said , chairman and chief executive officer, Express Scripts.
Trending on the Topix Network
Thu Apr 17, 2014
Drugstore Wars: Walgreen Vs. CVS
I hope I'm not dating myself too much, but I remember when the neighborhood chain drugstore was almost a one-stop shop for human needs.
Tue Apr 15, 2014
Belleville News Democrat
Daily business briefing: St. Louis execs among nation's highest paid
Some St. Louis executives have landed on the Equilar 100 CEO Pay Study. The median pay for the 100 CEOs on the list was $13.9 million, up 9 percent from last year.
New health exchange enrollees are using lots of specialty drugs, but few contraceptives
Express Scripts analyzed pharmacy benefit claims from 400,000 exchange members covered by the company from Jan. 1 to Feb. 28. Early data released by the nation's largest pharmacy benefits manager provides a snapshot of the health of the individuals who have so far enrolled in the health insurance exchanges that are part of the Affordable Care Act.
Mon Apr 14, 2014
Bristol-Myers submits NDA for Reyataz-cobicistat combo for HIV-1
Attack on Gilead Sovaldi by Express Scripts 'noise,' says Maxim After Bloomberg reported that Express Scripts said that it would attempt to build a coalition against the use of Gilead's Sovaldi once a rival drug is approved, Maxim views Express Scripts' statement as "noise."
Sat Apr 12, 2014
Cost of highly effective hepatitis drug spurs revolt
And at $1,000 a daily pill, or $84,000 over 12 weeks of treatment, the medication could generate as much as $19 billion nationwide in revenue in the next three years for maker Gilead Sciences in Foster City.
Fri Apr 11, 2014
Investment Analysts' Ratings Reiterations for April, 11th (ASOMF,...
They currently have a $52.00 target price on the stock. Zacks' analyst wrote, "We have maintained our Neutral recommendation on Avery Dennison with a target price of $52.00.
Thu Apr 10, 2014
Spike in use of compounded medications leads workers comp cost increases
The utilization and cost of compounded medications in workers compensation claims spiked last year, while the costs of antidepressants and non-narcotic painkillers also continued to rise, according to a report released Thursday by pharmacy benefit manager Express Scripts Inc. The use of compounded medications, which include oral and topical ... (more)
ISI Group Lowers Express Scripts Holding Company Price Target to $75.00
ISI Group's price target suggests a potential upside of 1.05% from the stock's previous close.
Wed Apr 09, 2014
Report: Exchanges yield more specialty drug claims
Patients from the health care overhaul's new insurance exchanges have been more likely to use expensive specialty drugs for chronic conditions, according to data from the nation's largest pharmacy benefits manager.
Gilead Sciences: Pricing Concerns Just Noise?
Maxim Group's Jason Kolbert thinks the controversy over the cost of Gilead Sciences' Sovaldi is overblown.
Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force ...
Express Scripts plans to ask its clients, which include employers, health insurance plans and government agencies, to join a group that would stop using Gilead's Sovaldi treatment for Hepatitis C once the FDA has approved rival drugs.
Tue Apr 08, 2014
The Washington Post
Express Scripts Raises Pressure on Gilead to Cut Drug Price
Express Scripts Holding Co., a pharmacy benefit manager that handles more than 1 billion prescriptions a year in the U.S., is ratcheting up its effort to force Gilead Sciences Inc. to cut the $84,000 price of its new hepatitis C pill Sovaldi.
Mon Apr 07, 2014
KSDK-TV Saint Louis
St. Louis Career Fair this weekSt. Louis Career Fair this weekExpress ...
Express Scripts and Job News are sponsoring the St. Louis Career Fair this week at the Doubletree Hotel in Westport Plaza.
Applied Clinical Trials
United BioSource Corp. Named Preferred Oncology Clinical Research...
United BioSource Corp. , a subsidiary of Express Scripts ESRX , has been named the preferred oncology clinical research partner by RT Oncology Services Corp. , the nation's leading community oncology alliance.
The Motley Fool
Can Express Scripts Holding Co. Beat Expectations Again?
Analysts are skeptical that, with the large advances already made in the shift to generics, Express Scripts can leverage formulary design, producer discounts, mail delivery and other drivers to continue generating double-digit free cash flow growth.
Thu Apr 03, 2014
Commentary: Immigrants Will Help Rebuild St. Louis
St. Louis has long benefited from immigrants. At the turn of the 20th century, St. Louis had almost 600,000 inhabitants, making it the fourth largest city in the nation behind New York, Chicago and Philadelphia.
Thursday's ETF with Unusual Volume: IHF
The iShares U.S. Healthcare Providers ETF is seeing unusually high volume in afternoon trading Thursday, with over 245,000 shares traded versus three month average volume of about 28,000.
Tue Apr 01, 2014
Express Scripts Holding Company PT Raised to $86.00
Jefferies Group's price target would indicate a potential upside of 13.04% from the company's current price.
Thu Mar 27, 2014
Express Scripts' George Paz sees jump in pay
Express Scripts Chairman and CEO George Paz's total compensation in 2013 was $13.04 million, an increase from his $12.75 million total compensation in 2012, according to the company's proxy statement.